NEW YORK, Dec 18, 2007 (Thomson Financial via COMTEX) -- BFRM charts news PowerRating -- Shares of BioForm Medical Inc. skyrocketed Monday after CIBC World Markets initiated coverage of the company with a sector outperformer rating and a $12 price range because of the company's anticipated success with new wrinkle-filler product Radiesse.
The shares rose 31.2% to $7.61.
BioForm also has in its pipeline a superficial treatment for varicose veins, Aethoxysklerol, which should get approval from the Food and Drug Administration before the end of 2009, CIBC said.
Monday, December 17, 2007
BioForm Medical shares soar
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment